Global Metabolite Profiling of Human Colorectal Cancer Xenografts in Mice Using HPLC–MS/MS
Citations Over TimeTop 25% of 2013 papers
Abstract
Reversed-phase gradient LC-MS was used to perform untargeted metabonomic analysis on extracts of human colorectal cancer (CRC) cell lines (COLO 205, HT-29, HCT 116 and SW620) subcutaneously implanted into age-matched athymic nude male mice to study small molecule metabolic profiles and examine possible correlations with human cancer biopsies. Following high mass accuracy data analysis using MS and MS/MS, metabolites were identified by searching against major metabolite databases including METLIN, MASSBANK, The Human Metabolome Database, PubChem, Biospider, LipidMaps and KEGG. HT-29 and COLO 205 tumor xenografts showed a distribution of metabolites that differed from SW620 and HCT 116 xenografts (predominantly on the basis of relative differences in the amounts of amino acids and lipids detected). This finding is consistent with NMR-based analysis of human colorectal tissue, where the metabolite profiles of HT-29 tumors exhibit the greatest similarity to human rectal cancer tissue with respect to changes in the relative amounts of lipids and choline-containing compounds. As the metabolic signatures of cancer cells result from oncogene-directed metabolic reprogramming, the HT-29 xenografts in mice may prove to be a useful model to further study the tumor microenvironment and cancer biology.
Related Papers
- → Is metabolomics reachable? Different purification strategies of human colon cancer cells provide different CE‐MS metabolite profiles(2011)50 cited
- → Plant metabolomics coming of age(2007)45 cited
- → Metabolomics and Secondary Metabolite Profiling of Filamentous Fungi(2015)17 cited
- → Capillary Electrophoresis–Mass Spectrometry for Metabolomics – From Metabolite Analysis to Metabolic Profiling(2018)3 cited
- Metabolite profiling study on fecal samples of type 2 diabetes rats by ultra-performance liquid chromatography-mass spectrometry(2009)